5-amino-1,3-oxazole derivatives and 1,3-oxazole-5-sulfonamides as novel agents against human cytomegalovirus

PL451792A1Pending Publication Date: 2026-10-19INST BIOLOGII MEDYCZNEJ POLSKIEJ AKADI NAUK +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: PL2025451792
Authority / Receiving Office: PL · PL
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-04-14
Publication Date: 2026-10-19

Application Information

Patent Timeline

14 Apr 2025

Application

PL2025451792

19 Oct 2026

Publication

PL451792A1

IPC: C07D263/02; C07D413/04; C07D413/12; A61K31/421; A61K31/422; A61P31/12

Inventors: AGNIESZKA OLEJNICZAK; MARTA DENEL-BOBROWSKA

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

1,3-Oxazole derivatives modified with amino groups, a method for their preparation, and their use are disclosed. These compounds can be used against human cytomegalovirus and the diseases caused by it.

Need to check novelty before this filing date? Find Prior Art